PERSPECTA

News from every angle

← Back to headlines

BioMarin Pharmaceutical Inc. (BMRN) Seen as Attractive Buy Ahead of Transcon-CNP PDUFA, Says Wells Fargo

26 Feb, 17:36 — 26 Feb, 17:36
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

Yahoo5d ago

BioMarin Pharmaceutical Inc. (BMRN) Seen as Attractive Buy Ahead of Transcon-CNP PDUFA, Says Wells Fargo

Read full article →

Related Stories

27-Year-Old British Woman Saves €115K for Early Retirement Using 5 Tricks

21m ago

A low credit score could cost you nearly $400 in interest each year. Here's how to fix it

28m ago

PennantPark Investment Declares Dividend

31m ago

NASB Financial Declares Dividend

32m ago